Scribd Logo
Upload

Welcome to Scribd!

  • 1K views

    Clopidogrel Bisulfate (PLOGREL)

    Uploaded by

    Kristine Young
    The document summarizes a drug study for a 68-year-old patient taking Clopidogrel (Plogrel) to prevent thromboembolic events for elevated blood pressure. It lists the drug's dosage of 75mg once daily by mouth, its mechanism of inhibiting platelet aggregation, and indications for preventing clotting events. Potential adverse reactions include bleeding, diarrhea, rash, and confusion. Nurses are responsible for checking orders, medication administration and education, and reporting any unusual bleeding or bruising to the prescriber.

    Copyright:

    © All Rights Reserved
    Download as DOC, PDF, TXT or read online from Scribd

    Clopidogrel Bisulfate (PLOGREL)

    Uploaded by

    Kristine Young
    1K views2 pages
    The document summarizes a drug study for a 68-year-old patient taking Clopidogrel (Plogrel) to prevent thromboembolic events for elevated blood pressure. It lists the drug's dosage of 75mg once daily by mouth, its mechanism of inhibiting platelet aggregation, and indications for preventing clotting events. Potential adverse reactions include bleeding, diarrhea, rash, and confusion. Nurses are responsible for checking orders, medication administration and education, and reporting any unusual bleeding or bruising to the prescriber.

    Original Description:

    Original Title

    Clopidogrel bisulfate (PLOGREL)

    Copyright

    © © All Rights Reserved

    Available Formats

    DOC, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    The document summarizes a drug study for a 68-year-old patient taking Clopidogrel (Plogrel) to prevent thromboembolic events for elevated blood pressure. It lists the drug's dosage of 75mg once daily by mouth, its mechanism of inhibiting platelet aggregation, and indications for preventing clotting events. Potential adverse reactions include bleeding, diarrhea, rash, and confusion. Nurses are responsible for checking orders, medication administration and education, and reporting any unusual bleeding or bruising to the prescriber.

    Copyright:

    © All Rights Reserved
    Download as DOC, PDF, TXT or read online from Scribd
    Download as doc, pdf, or txt
    1K views2 pages

    Clopidogrel Bisulfate (PLOGREL)

    Uploaded by

    Kristine Young
    The document summarizes a drug study for a 68-year-old patient taking Clopidogrel (Plogrel) to prevent thromboembolic events for elevated blood pressure. It lists the drug's dosage of 75mg once daily by mouth, its mechanism of inhibiting platelet aggregation, and indications for preventing clotting events. Potential adverse reactions include bleeding, diarrhea, rash, and confusion. Nurses are responsible for checking orders, medication administration and education, and reporting any unusual bleeding or bruising to the prescriber.

    Copyright:

    © All Rights Reserved
    Download as DOC, PDF, TXT or read online from Scribd
    Download as doc, pdf, or txt
    of 2

    St.

    Anthony’s College
    Nursing Department

    DRUG STUDY
    Name of Patient: AJS Attending Physician: Dr.JT
    Age: 68 yrs.old Ward/Bed Number: RESPI 2 Impression/ Diagnosis: Elevated Blood Pressure

    Name of Drug Dosage, Mech. of Indication Adverse Special Nursing


    Route, Action Reactions Precautions Responsibilities
    Freq.,
    Timing
    Generic: Dosage: Inhibits the Prevent Use cautiously  Check the
    Clopidogrel 75mg 1 tab binding of thromboembolic in patients at physicians order.
    bisulfate adenosine events risk for  Follow the
    diphosphate increased 14rights of
    Route: (ADP) to its bleeding from medication
    NGT platelet trauma,  Instruct patient to
    Brand: receptor, surgery or notify prescriber
    Plogrel impeding ADP- other if unusual
    mediated pathologic bleeding or
    activation and conditions and bruising occurs.
    Frequency subsequent in those with  Inform patient
    : renal or that drug may be
    platelet
    OD hepatic taken without
    aggregation,
    Classification: Contraindications Side Effects: impairment regard to meals
    and irreversibly
    :
    modifies the
    Therapeutic: Contraindicated in
    Timing: platelet ADP CNS: confusion,
    Antiplatelet drugs patients
    8am receptor. hypersensitive to fatal intracranial
    drug or its bleeding,
    components, in hallucinations
    those with a history CV: hypotension
    of hypersensitivity EENT: epistaxis,
    Pharmacological or hematologic rhinitis, taste
    : reaction to other disorder
    Platelet thienopyridines, GI:
    aggregation and in those with haemorrhage,
    inhibitors pathologic bleeding abdominal pain,
    constipation,
    (such as peptic diarrhea,
    ulcer or intracranial dyspepsia,
    haemorrhage. gastritis, ulcers.
    GU: UTI,
    hematuria
    Hematologic:
    thrombotic
    thrombocytopeni
    c purpura.
    Musculoskeletal
    : arthralgia,
    myalgia, arthritis
    Respiratory:
    bronchospasm,
    interstitial
    pneumonitis,
    respiratory tract
    bleeding
    Skin: rash,
    pruritus, bruising,
    eczema,
    erythema
    multiforme,
    urticarial,
    Stevens-Johnson
    syndrome, toxic
    epidermal
    necrolysis
    Other: flulike
    syndrome,
    angioedema,
    anaphylaxis,
    serum sickness

    Student’s Name: John Carlo Toledo


    Clinical Instructor: Melchor Cercado , RN.

    You might also like